A team bound by a shared vision
MagIA diagnostics innovative diagnostic technology is the culmination of a remarkable 15-year collaboration among several research institutes based in Grenoble, France. Our innovation, protected by multiple patents, employs magnetic interactions at the submillimeter scale for pathogen detection. The developed immunoassay has been extensively studied in various theses, unveiling its versatility across various biological parameters, its substantial clinical potential, and its suitability for industrial applications. The team was mentored by a local incubator, the SATT Linksium Grenoble. During this time, the MagIA technology was improved with the help of medical doctors, diagnostics experts and pharmaceutical companies in order to create practical solutions for our future customers.
In 2017, after two years of incubation and mentoring, the legal entity MagIA diagnostics was born. From the very beginning, the entrepreneurial spirit of the team was led by the ambition to make a deeptech breakthrough available to as many people as possible and have a major impact on the most serious public health issues.